Major role of organic anion transporters in the uptake of phenolsulfonphthalein in the kidney

https://doi.org/10.1016/S0014-2999(03)02111-3Get rights and content

Abstract

Phenolsulfonphthalein is used for testing renal function. However, its excretion mechanism has not been elucidated. The purpose of this study was therefore to elucidate the transporter-mediated excretion system for phenolsulfonphthalein. p-Aminohippuric acid, a substrate of rat organic anion transporter1 (rOat1), and cimetidine, a substrate of rOat3, reduced the urinary excretion of phenolsulfonphthalein. The uptake of phenolsulfonphthalein by kidney slices was found to consist of two components. The IC50 values of rOat1 substrates were higher than those of rOat3 substrates. In the presence of cimetidine, the Eadie–Hofstee plot gave a single straight line. The profile of the phenolsulfonphthalein uptake component in the presence of cimetidine was similar to that of the low-affinity component in the absence of cimetidine. We conclude that rOat1 and rOat3 are involved in the renal uptake of phenolsulfonphthalein and that phenolsulfonphthalein is a high-affinity substrate for rOat3 but is a relatively low-affinity substrate for rOat1.

Introduction

The kidney plays an important role in the urinary excretion of drugs and their metabolites via glomerular filtration and tubular secretion. The first step in tubular secretion is the uptake from blood through the basolateral membrane of epithelial cells in the proximal tubules. Transporter-mediated systems have been considered to play major roles in the tubular drug uptake. p-Aminohippuric acid is widely used as a model substrate to investigate renal handling of organic anions because of its high renal clearance and susceptibility to metabolism. Rat organic anion transporter 1 (rOat1/Slc22a6) has recently been isolated and identified as a basolateral p-aminohippuric acid transporter (Sweet et al., 1997). Phenolsulfonphthalein is widely used clinically as a drug for testing renal function because of its high renal clearance (Gault et al., 1967). However, it is thought that phenolsulfonphthalein and p-aminohippuric acid do not to share the same transporter system at the basolateral membrane of proximal tubular cells (Pritchard and Miller, 1992). An accumulation step across the basolateral membrane has been demonstrated. However, the transporters responsible for the renal uptake of phenolsulfonphthalein are not fully understood.

To date, another rOats, named rOat2 (Slc22a7) and rOat3 (Slc22a8), have been identified Kusuhara et al., 1999, Sekine et al., 1998. However, rOat2 and rOat1/3 are transcripts from separate genes located on different chromosomes. rOat2 was first cloned as a novel liver transporter NLT (Simonson et al., 1994). rOat1 and rOat3 are the only organic anion transporters that are localized to the basolateral membrane of proximal tubules Sekine et al., 2000, Tojo et al., 1999. rOat1 and rOat3 mediate the transport of many organic anions including endogenous metabolites, drugs and xenobiotics. It is thought to be the most important physiological process involved in the basolateral uptake of organic anions in renal epithelial cells (Sekine et al., 2000). It has been demonstrated that rOat1 mediates the transport of relatively small hydrophilic organic anions such as p-aminohippuric acid (Uwai et al., 1998). In contrast, the preferred substrates for rOat3 are larger and more hydrophobic compounds (Cha et al., 2001). There is a little information about the contribution of rOat1 and rOat3 to the total renal uptake of organic anions. The aim of the present study was to determine the validity of the hypothesis that phenolsulfonphthalein is cleared from peritubular blood by rat kidney organic anion transporters, particularly by rOat1 and rOat3, and to determine the contribution of rOat1 and rOat3 to the renal uptake of phenolsulfonphthalein. The results demonstrated that phenolsulfonphthalein is a high-affinity substrate for rOat3 but is a relatively low-affinity substrate for rOat1.

Section snippets

Chemicals

Phenolsulfonphthalein, cimetidine, salicylate and p-aminohippuric acid were purchased from Wako (Osaka, Japan). Pravastatin was kindly donated from Sankyo (Tokyo, Japan). [3H]p-Aminohippuric acid was purchased from NEN Life Science Products (Hoofddrop, The Netherlands). All other reagents were of the highest grade available and used without further purification.

Animals

Male Wistar rats, aged 6–7 weeks (300–350 g in weight), were obtained from NRC Haruna (Gunma, Japan). The experimental protocols were

Inhibitory effects of various drugs on urinary excretion of phenolsulfonphthalein

To characterize the uptake process for phenolsulfonphthalein by the kidney in vivo, the inhibitory effects of p-aminohippuric acid, a relatively specific substrate of rOat1, and cimetidine, a specific substrate of rOat3, on the urinary excretion of phenolsulfonphthalein were determined Hasegawa et al., 2002, Nagata et al., 2002. The amount of urinary excretion of phenolsulfonphthalein over a period of 1 hr after intravenous injection in Wistar rats is shown in Fig. 1. p-Aminohippuric acid and

Discussion

Phenolsulfonphthalein is normally excreted by the kidneys in humans (Gault et al., 1967). Thus, phenolsulfonphthalein has been used widely to assess renal function. However, the renal uptake mechanism has not been clarified yet. rOat1 and rOat3 mediate the initial active step in the process of organic anion secretion across the proximal tubule Sekine et al., 2000, Tojo et al., 1999. The aim of the present study was to determine whether phenolsulfonphthalein is a substrate for rOat1 and rOat3,

References (31)

Cited by (19)

  • Phenolsulfonphthalein as a surrogate substrate to assess altered function of the prostaglandin transporter SLCO2A1

    2022, Drug Metabolism and Pharmacokinetics
    Citation Excerpt :

    In humans, PSP is mainly eliminated from kidney [17], whereas it was eliminated from both kidney and liver in rodents [18,19]. Previous literature suggests that renal secretion and hepatobiliary excretion of PSP could be mediated by organic anion transporter (Oat) 1/Slc22a6 and Oat3/Slc22a8, and by multidrug resistance-associated protein (Mrp) 2/Abcc2, respectively [20,21]. Since intraperitoneally injected PSP is efficiently secreted to lower airway mucosa, its characteristic distribution to the lungs is used for pharmacological validation of expectorant drugs in a mouse model [22].

  • Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models

    2019, Asian Journal of Pharmaceutical Sciences
    Citation Excerpt :

    To support results of mRNA induction, the protein expression of these transporters was not checked in this study. We expected that an in vivo pharmacokinetic study after multiple-dose quercetin administration in rats can be used to detect functional changes in these transporters because PSP is a co-substrate of MRP2/Mrp2, Oatp1B1, Oat1, and Oat3 [31,32]. The inhibitory effect of quercetin on Mrp2 in vitro was also evaluated by an in vivo pharmacokinetic study of PSP in rats.

  • The oligopeptide transporter 2-mediated reabsorption of entecavir in rat kidney

    2014, European Journal of Pharmaceutical Sciences
    Citation Excerpt :

    When entecavir was administrated in clinical, PEPT2 mediated-toxicity should be paid attention. The Eadie–Hofstee plot of our data showed two obviously different transport systems: a low-affinity, high-velocity system and a high-affinity, low-velocity system (Fig. 2; Table 1), and other studies had reported similar results (Han et al., 2010; Itagaki et al., 2003). This interesting phenomenon might be the result of two distinct binding modes between entecavir and PEPT2 and needed to be clarified in further studies.

View all citing articles on Scopus
View full text